Journals / Ulusal Cerrahi Dergisi / 2013 / Cilt: 29 - Sayı: 4

Clinical nutrition and drug interactions

Klinik nütrisyon ve ilaç etkileşimleri

Pages
177–186
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, since the pharmacists are well-experienced and more knowledgeable professionals in drugs and drug usage compared to other healthcare providers, it is suggested that provision of information and drug counselling by pharmacists in terms of detection and prevention of problems (such as interactions, stability, incompatibility) related with enteral/parenteral nutrition and drugs are invaluable in clinical practice

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A drug’s plasma level, pharmacological effects or side effects, elimination, physicochemical properties or stabil- ity could be changed by interactions of drug-drug or drug-nutrition products in patients who receive enteral or parenteral nutritional support.
📊
Key Findings & Data:Although administration of drugs via feeding tube is a complex and problematic route for drug usage, it is possible to minimise the risk of tube occlusion, decreased effects of drug and drug toxicity by using an appropriate technique.
💡
Conclusion & Impact:In conclusion, since the pharmacists are well-experienced and more knowledgeable professionals in drugs and drug usage compared to other healthcare providers, it is suggested that provision of information and drug counselling by pharmacists in terms of detection and prevention of problems (such as interactions, stability, incompatibility) related with enteral/parenteral nutrition and drugs are invaluable in clinical practice
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A drug’s plasma level, pharmacological effects or side effects, elimination, physicochemical properties or stabil- ity could be changed by interactions of drug-drug or drug-nutrition products in patients who receive enteral or parenteral nutritional support. As a result, patients might experience ineffective outcomes or unexpected effects of therapy (such as drug toxicity, embolism). Stability or incompatibility problems between parenteral nutrition admixtures and drugs might lead to alterations in expected therapeutic responses from drug and/or parenteral nutrition, occlusion in venous catheter or symptoms or mortality due to infusion of composed particles. Compat- ibilities between parenteral nutrition and drugs are not always guaranteed in clinical practice. Although the list of compatibility or incompatibilities of drugs are published for the use of clinicians in their practices, factors such as composition of parenteral nutrition admixture, drug concentration, contact time in catheter, temperature of the environment and exposure to light could change the status of compatibilities between drugs and nutrition admix- tures. There could be substantial clinical changes occur in the patient’s nutritional status and pharmacological effects of drugs due to interactions between enteral nutrition and drugs. Drug toxicity and ineffective nutritional support might occur as a result of those predictable interactions. Although administration of drugs via feeding tube is a complex and problematic route for drug usage, it is possible to minimise the risk of tube occlusion, decreased effects of drug and drug toxicity by using an appropriate technique. Therefore, it is important to consider pharma- cological dosage forms of drugs while administering drugs via a feeding tube. In conclusion, since the pharmacists are well-experienced and more knowledgeable professionals in drugs and drug usage compared to other healthcare providers, it is suggested that provision of information and drug counselling by pharmacists in terms of detection and prevention of problems (such as interactions, stability, incompatibility) related with enteral/parenteral nutrition and drugs are invaluable in clinical practice

Özet

Enteral veya parenteral nütrisyon desteği alan hastaların kullanmakta olduğu ilaçların birbirleri veya nütrisyon ürünleri ile etkileşmesine bağlı olarak ilacın kan düzeyi, etkisi veya yan etkisi, vücuttan atılımı, fizikokimyasal özelliği ve stabilitesi gibi özellikleri değişebilmektedir. Bunun sonucu, tedaviden yeterli sonuç alınamayabilmek- te veya hastada istenmeyen sorunlar (ilaç toksisitesi, emboli gibi) ortaya çıkabilmektedir. Parenteral nütrisyon karışımları ile ilaçlar arasındaki geçimsizlik veya stabilite sorunları; ilaçtan ve/veya parenteral beslenmeden bek- lenen terapötik cevabın değişmesine, venöz kateterin tıkanmasına veya oluşan partiküllerin infüzyonu sonucu semptomlara veya ölüme yol açabilmektedir. Parenteral nütrisyon karışımları ile ilaçlar arasındaki geçimlilik klinik uygulamalarda asla garanti edilememektedir. Geçimli olan ve geçimsizlik gösteren ilaçlara ait hazırlan- mış listeler klinisyenlerin işini kolaylaştırsa da, parenteral nütrisyon karışımının içeriği, ilacın konsantrasyonu, kateterdeki temas süresi, ortamın sıcaklığı ve ışığa maruziyet gibi faktörler ilaç-nütrisyon karışımları arasındaki geçimlilik durumunu değiştirebilmektedir. Enteral nütrisyon ile ilaç etkileşimi sonucu, hastaların nütrisyonel durumunda ve ilaçtan beklenen farmakolojik etkide, klinik olarak önemli değişiklikler meydana gelebilmek- tedir. Öngörülebilen bu etkileşimler sonucunda uygulanan tedaviden ve nütrisyon desteğinden yeterli sonuç alınamayabilmekte veya ilaç toksisitesi ortaya çıkabilmektedir. Beslenme tüpünden ilaç uygulaması, karmaşık ve problemli bir uygulama yolu olduğundan, ancak uygun teknik ile ilaç uygulanması sonucunda, tüp tıkanma riski, ilaç etkisinde azalma veya ilaç toksisitesinin en aza indirilebilmesi mümkün olmaktadır. Bu nedenle beslenme tüpünden ilaç uygulanmasında, ilaçların farmasötik dozaj şekillerinin de göz önünde tutulması gerekmektedir. Diğer sağlık hizmet sunucularına kıyasla ilaç konusunda en uzun ve detaylı eğitimi alan eczacıların, enteral/ parenteral nütrisyon ve ilaçlarla ilgili sorunların saptanması (etkileşim, geçimsizlik, stabilite gibi) ve çözülmesi amacı ile, klinik uygulamalarda mesleki bilgilerinden faydalanılmalıdır

🔖

Cite This Article

EKİNCİOĞLU, A. B., DEMİRKAN, K. (2013). Clinical nutrition and drug interactions. Ulusal Cerrahi Dergisi, Cilt: 29 - Sayı: 4, 177–186. https://ajindex.com/articles/325456

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Chan LN. Drug-nutrient interaction in clinical nutrition. Curr Opin Clin Nutr Metab Care 2002
  2. [CrossRef] 2. Teitelbaum D, Guenter P, Howell WH, Kochevar ME, Roth J, Seidner DL. Definition of terms, style, and conventions used in A.S.P.E.N. guidelines and standards. Nutr Clin Pract 2005
  3. [CrossRef] 3. Hadaway LC. Administering parenteral nutrition with other I.V. drugs. Nursing 2005
  4. [CrossRef] 4. Sacks GS. Drug-nutrient considerations in patients receiving parenteral and enteral nutrition. Practical Gastroenterology 2004
  5. Mattox TW, Reiter PD. Parenteral nutrition. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy: A Pathophysiologic Approach 6th ed. New York: Appleton & Lange
  6. p.2591-2613. 6. Mühlebach S. İlaçlar ve beslenme ürünlerinin karışımları. In: Sobotka L, editor. Klinik Nutrisyon Temel Kavramlar Kitabı. İkinci baskı. İstanbul: Logos Yayıncılık
  7. p.263-269. 7. Mühlebach S, Franken C, Stanga Z. Practical handling of AIO admixtures - guidelines on parenteral nutrition. German Medical Science 2009
  8. Mirtallo JM. Drug-nutrient interactions in patients receiving parenteral nutrition. In: Boullata JI, Armenti VT, editors. Handbook of Drug-Nutrient Interactions. 2nd ed. New York: Humana Press
  9. p.411-424. 9. Trissel LA, Xu QA, Baker M. Drug compatibility with new polyolefin infusion solution containers. Am J Health Syst Pharm 2006
  10. [CrossRef] 10. Puzovic M, Hardy G. Stability and compatibility of histamine H2- receptor antagonists in parenteral nutrition mixtures. Curr Opin Clin Nutr Metab Care 2007
  11. [CrossRef] 11. Bone BM, Maksym CJ, Kirking DM, Georgal BA, Jarvis CL, DunnKucharski VA, et al. Intravenous histamine H2-receptor antagonists and parenteral nutrition: patterns of use. Am J Health Syst Pharm 1995
  12. Cohen MR. Safe practices for compounding of parenteral nutrition. JPEN J Parenter Enteral Nutr 2012
  13. [CrossRef] 13. Shearer MJ. Vitamin K in parenteral nutrition. Gastroenterology 2009
  14. [CrossRef] 14. Earl-Salotti GI, Charland SL. The effect of parenteral nutrition on hepatic cytochrome P-450. JPEN J Parenter Enteral Nutr 1994
  15. [CrossRef] 15. Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM. Compatibility of medications with 3-in-1 parenteral nutrition admixtures. JPEN J Parenter Enteral Nutr 1999
  16. [CrossRef] 16. Schuetz